Manufacturing / Biological Products, Except Diagnostic Substances
RECURSION PHARMACEUTICALS, INC.
RXRX
$3.52
+$0.26 (+8.00%)
Price as of Aug 25, 2026 15:45 UTC
1.7 B
Market Cap (Small Cap)
10%
IV Rank
78.2%
Implied Volatility
Nov 03
Next Earnings
Price & Trend
Daily candles with EMA 20, SMA 50. Drag to zoom.
Options Activity & Greeks
Implied volatility, flow, and dealer positioning from the options market.
Put/Call Ratio
0.19
Bullish skew
Implied Volatility
78.2%
0% percentile
IV vs Realized
Options rich
30d HV 66.7%
Options Heat Map
Delta-risk grid for RXRX options across strikes and expirations. Hover any cell for full Greeks.
Loading option chain data...
Insider Trades
0 buys
39 sells
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| Aug 04, 2026 | Borgeson Blake | Sell | 30,000 | $97,500 | |
| Jul 07, 2026 | Borgeson Blake | Sell | 40,000 | $158,500 | |
| Jul 01, 2026 | Li Dean Y | Grant | 3,747 | $0 | |
| Jul 01, 2026 | Dar Zavain | Grant | 5,109 | $0 | |
| Jun 18, 2026 | Bumpus Namandje | Sell | 3,963 | $12,602 | |
| Jun 17, 2026 | Dar Zavain | Grant | 88,424 | $0 | |
| Jun 17, 2026 | Sun Elaine D | Grant | 88,424 | $0 | |
| Jun 17, 2026 | Michor Franziska | Grant | 88,424 | $0 | |
| Jun 17, 2026 | Borgeson Blake | Grant | 88,424 | $0 | |
| Jun 17, 2026 | HERSHBERG ROBERT | Grant | 88,424 | $0 |
Earnings History
| Date | Quarter | EPS Est. | EPS Actual | Surprise | Result |
|---|---|---|---|---|---|
| Aug 11, 2026 | Q2 2026 | -$0.24 | |||
| Aug 05, 2026 | Q2 2026 | -$0.24 | |||
| Aug 03, 2026 | Q2 2026 | -$0.24 | |||
| Jun 30, 2026 | Q2 2026 | -$0.24 | -$0.25 | -4.7% | Miss |
| Mar 31, 2026 | Q1 2026 | -$0.28 | -$0.22 | +20.5% | Beat |
| Dec 31, 2025 | Q4 2025 | -$0.32 | -$0.21 | +34.8% | Beat |
| Sep 30, 2025 | Q3 2025 | -$0.38 | -$0.36 | +4.6% | Beat |
| Jun 30, 2025 | Q2 2025 | -$0.36 | -$0.41 | -14.8% | Miss |
Track RXRX with ThetaPal
Get insider trade alerts, AI portfolio analysis, and options roll recommendations for RXRX and your entire portfolio.